Dogan, E. Et Al. 2012. Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience. MEDICAL ONCOLOGY , vol.29, no.5 , 3232-3239.

Dogan, E., YORGUN, H., Petekkaya, I., ÖZER, N., Altundag, K., & Ozisik, Y., (2012). Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience. MEDICAL ONCOLOGY , vol.29, no.5, 3232-3239.

Dogan, Erkan Et Al. "Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience," MEDICAL ONCOLOGY , vol.29, no.5, 3232-3239, 2012

Dogan, Erkan Et Al. "Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience." MEDICAL ONCOLOGY , vol.29, no.5, pp.3232-3239, 2012

Dogan, E. Et Al. (2012) . "Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience." MEDICAL ONCOLOGY , vol.29, no.5, pp.3232-3239.

@article{article, author={Erkan Dogan Et Al. }, title={Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience}, journal={MEDICAL ONCOLOGY}, year=2012, pages={3232-3239} }